Aptamer Sciences Inc (291650.KQ) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · South Korea
Aptamer Sciences Inc financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 1.08 bn KRW | 3.50 bn KRW |
| Gross profit | -1.63 bn KRW | 1.69 bn KRW |
| Operating income | -6.87 bn KRW | -7.80 bn KRW |
| EBIT | -7.35 bn KRW | -8.30 bn KRW |
| Net income | -8.70 bn KRW | -8.62 bn KRW |
| Diluted EPS – continuing operations | -297.21 KRW | -428.33 KRW |
Full history since 2018, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Aptamer Sciences Inc
CHOOLIP & SCIENCES Inc., a bio venture company, focuses on the Aptamer technology platform for the development of therapeutic and diagnostic platforms. The company's platforms include aptamer discovery, optimization, and the development of therapeutics and diagnostics for cancer and neurological disorders. It offers AlloMAp and Bi-Functional Aptame (BiFAp) platform programs for therapeutics, as well as Aptodetect-lung, an early diagnosis kit for lung cancer. The company was formerly known as Aptamer Sciences Inc and changed its name to CHOOLIP & SCIENCES Inc. in August 2026. CHOOLIP & SCIENCES Inc. was founded in 2011 and is headquartered in Seongnam-si, South Korea.
More stocks
- Samho Dev (010960.KS)
- Xavi Technologies Corp. (3447.TW)
- KH Group Oyj (KHG.HE)
- InkTec Co. Ltd (049550.KQ)
- Naturalendo Tech Co Ltd (168330.KQ)
- MiNK Therapeutics, Inc. (INKT)
- Endurance Gold Corp (EDG.V)
- Hae In (003010.KS)
- Greenland Mines Ltd (GRML)
- EgnsINVEST Ejendomme Tyskland A/S (EGNETY.CO)
- Inter Logistico Fundo De Investimento Imobiliario - FII (INLG11.SA)
- Kukje Pharma Co Ltd (002720.KS)
Not investment advice. All data without warranty, price as of 17.11.2026. Details in the risk notice.